You are not currently logged in.
Access JSTOR through your library or other institution:
Design of Aromatic Inhibitors of Influenza Virus Neuraminidase
Ming Luo, Gillian M. Air and Wayne J. Brouillette
The Journal of Infectious Diseases
Vol. 176, Supplement 1. Pandemic Influenza: Confronting a Re-Emergent Threat (Aug., 1997), pp. S62-S65
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30106839
Page Count: 4
You can always find the topics here!Topics: Active sites, Orthomyxoviridae, Functional groups, Drug design, Proteins, Influenza, Drug interactions, Viral morphology, Binding sites, Amino acids
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Structure-based drug design, a terminology used to describe rational drug design by complementing the structure, spatially and chemically, of the target macromolecule, is rapidly developing as one of the innovative approaches to drug discovery. A growing volume of protein structure data and new techniques of protein structure determination make this all possible. The method of structure-based drug design and a specific example of the design of influenza virus neuraminidase is briefly presented. A whole new class of influenza virus neuraminidase inhibitors has been designed that can potentially be developed as antiinfluenza drugs.
The Journal of Infectious Diseases © 1997 Oxford University Press